__timestamp | Jazz Pharmaceuticals plc | Viking Therapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 85181000 | 22223073 |
Thursday, January 1, 2015 | 135253000 | 6966842 |
Friday, January 1, 2016 | 162297000 | 9000499 |
Sunday, January 1, 2017 | 198442000 | 13741186 |
Monday, January 1, 2018 | 226616000 | 19040000 |
Tuesday, January 1, 2019 | 299726000 | 23559000 |
Wednesday, January 1, 2020 | 335375000 | 31931000 |
Friday, January 1, 2021 | 505748000 | 44981000 |
Saturday, January 1, 2022 | 590453000 | 54234000 |
Sunday, January 1, 2023 | 849658000 | 63806000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Jazz Pharmaceuticals plc and Viking Therapeutics, Inc. have shown contrasting trajectories in their R&D investments over the past decade.
From 2014 to 2023, Jazz Pharmaceuticals has consistently increased its R&D expenses, culminating in a staggering 900% growth by 2023. This reflects their aggressive strategy to expand their drug pipeline and enhance their market position. In contrast, Viking Therapeutics, while also increasing its R&D spending, has done so at a more modest pace, with a 187% rise over the same period.
These trends highlight the differing scales and strategies of these two companies, with Jazz Pharmaceuticals taking a more expansive approach compared to the more cautious, yet steady, path of Viking Therapeutics.
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Analyzing R&D Budgets: Zoetis Inc. vs Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Viking Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Jazz Pharmaceuticals plc
Research and Development Investment: Jazz Pharmaceuticals plc vs Opthea Limited
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
Jazz Pharmaceuticals plc vs MannKind Corporation: Strategic Focus on R&D Spending
Research and Development Investment: Lantheus Holdings, Inc. vs Viking Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs MannKind Corporation